Invention Grant
- Patent Title: Organic compounds
-
Application No.: US15997438Application Date: 2018-06-04
-
Publication No.: US10238660B2Publication Date: 2019-03-26
- Inventor: Allen A. Fienberg , Lawrence P. Wennogle , Sharon Mates
- Applicant: INTRA-CELLULAR THERAPIES, INC.
- Applicant Address: US NY New York
- Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee Address: US NY New York
- Agency: Hoxie & Associates LLC
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K31/519
Abstract:
The present invention relates to a new use of phosphodiesterase 1 (PDE1) inhibitors for the treatment of psychosis, schizophrenia, schizoaffective disorder, schizophreniform disorder, psychotic disorder, delusional disorder, mania, or bipolar disorder.
Public/Granted literature
- US20180280396A1 ORGANIC COMPOUNDS Public/Granted day:2018-10-04
Information query
